SCISPARC LTD (SPRC) Stock Price, Forecast & Analysis
NASDAQ:SPRC • IL0010951403
SPRC Key Statistics, Chart & Performance
The current stock price of SPRC is 0.6079 USD. In the past month the price decreased by -49.96%. In the past year, price decreased by -94.15%.
SPRC Technical Analysis
SPRC Financial Highlights
Over the last trailing twelve months SPRC reported a non-GAAP Earnings per Share(EPS) of -22.63. The EPS increased by 91.42% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -122.18% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
SPRC Forecast & Estimates
SPRC Ownership
SPRC Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 31.35 | 959.759B | ||
| JNJ | JOHNSON & JOHNSON | 21.14 | 580.304B | ||
| MRK | MERCK & CO. INC. | 22.29 | 296.13B | ||
| PFE | PFIZER INC | 9.26 | 157.665B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.89 | 122.002B | ||
| ZTS | ZOETIS INC | 18.51 | 56.704B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.67 | 25.543B | ||
| VTRS | VIATRIS INC | 6.31 | 18.578B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.83 | 12.774B | ||
| AXSM | AXSOME THERAPEUTICS INC | 224.31 | 9.387B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SPRC
Company Profile
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Company Info
SCISPARC LTD
20 Raul Wallenberg Street, Tower A
TEL AVIV-YAFO IL
Employees: 2
Phone: 97236103100
SCISPARC LTD / SPRC FAQ
Can you describe the business of SCISPARC LTD?
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
What is the stock price of SCISPARC LTD today?
The current stock price of SPRC is 0.6079 USD. The price decreased by -0.83% in the last trading session.
Does SCISPARC LTD pay dividends?
SPRC does not pay a dividend.
What is the ChartMill rating of SCISPARC LTD stock?
SPRC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Which stock exchange lists SPRC stock?
SPRC stock is listed on the Nasdaq exchange.
What is the Price/Earnings (PE) ratio of SCISPARC LTD (SPRC)?
SCISPARC LTD (SPRC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-22.63).